Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Myositis × Rituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 234 Lymphoma, Non-Hodgkin 181 Leukemia, Lymphocytic, Chronic, B-Cell 171 Lymphoma, Large B-Cell, Diffuse 164 Lymphoma, Follicular 152 Lymphoma, Mantle-Cell 117 Leukemia 76 Lymphoma, B-Cell, Marginal Zone 71 Waldenstrom Macroglobulinemia 50 Burkitt Lymphoma 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Lymphoma, Large-Cell, Immunoblastic 39 Lymphoma, B-Cell 39 Hodgkin Disease 36 Recurrence 32 Lymphoma, Large-Cell, Anaplastic 15 Multiple Myeloma 14 Neoplasms 12 Myelodysplastic Syndromes 12 Hematologic Neoplasms 12 Leukemia, Myeloid, Acute 11 Intraocular Lymphoma 8 Dendritic Cell Sarcoma, Interdigitating 8 Leukemia, Prolymphocytic 7 Lymphoma, T-Cell 6 Leukemia, B-Cell 6 Neoplasms, Plasma Cell 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Arthritis, Rheumatoid 5 Myeloproliferative Disorders 4

Interventions

Rituximab 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00774462 2012-12-11

FORCE

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed

Myasthenia Gravis, Myositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡